The entry of new players and dozens of potentially disruptive mergers and acquisitions are pushing healthcare in nontraditional directions, yielding opportunities for cardiologists to help shape the transformation.
While three-dimensional printing has been used in various industries for more than three decades, it took medicine just three or so years to catapult the technology into the popular imagination. Among burgeoning areas of healthcare innovation, probably AI alone has made more headlines in that short a span. And life-size models of individual patients’ organs, which allow surgeons to carefully plan complex procedures and consult with patients and families, are just the start.
Known for its conservative and what many call risk-averse nature, the Food and Drug Administration (FDA) seems to be headed in a bold and ambitious direction under Commissioner Scott Gottlieb, MD. What will his leadership mean for cardiology?
The unrelenting growth of diabetes around the world is prompting cardiologists to rethink how they treat and manage a challenging patient population, even as an emerging class of cardio-protective diabetes drugs is setting the stage for transformation.
Physician burnout has been called a “silent epidemic” that not only overwhelms physicians but can impact the care they deliver to patients. A number of programs are starting to confront the problem head on—giving doctors hope that someone is listening.
After decades of steady progress pushing back the leading cause of death and disability, cardiologists are striving to achieve the Quadruple Aim as they prepare for a tidal wave of aging patients with multiple chronic conditions. Bellwether hospitals are rethinking old systems and carving out new pathways for managing “Chronic America.”